Top

Published in:

01-11-2010 | Report of the committee

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus

The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus

Authors: Yutaka Seino, Kishio Nanjo, Naoko Tajima, Takashi Kadowaki, Atsunori Kashiwagi, Eiichi Araki, Chikako Ito, Nobuya Inagaki, Yasuhiko Iwamoto, Masato Kasuga, Toshiaki Hanafusa, Masakazu Haneda, Kohjiro Ueki

Published in: Diabetology International | Issue 1/2010

Excerpt

Diabetes mellitus is a group of diseases associated with various metabolic disorders, the main feature of which is chronic hyperglycemia due to insufficient insulin action. Its pathogenesis involves both genetic and environmental factors. The long-term persistence of metabolic disorders can cause susceptibility to specific complications and also foster arteriosclerosis. Diabetes mellitus is associated with a broad range of clinical presentations, from being asymptomatic to ketoacidosis or coma, depending on the degree of metabolic disorder. …

Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc. 2010; 53:450–67. (Japanese).

Kuzuya N, Abe M, Ueda H, Kuzuya K, Kuzuya T, Kosaka K, Goto Y, Shigeta Y, Baba S, Hirata Y, Horiuchi A, Yamada K, Wada M. Report of the committee on the diagnostic criteria of the oral glucose tolerance test for diabetes mellitus. J Jpn Diabetes Soc. 1970;13:1–7. (in Japanese).

Kosaka K, Akanuma Y, Goto Y, Hagura R, Hirata Y, Kawate R, Kuzuya T, Mimura G, Nakayama H, Sakamoto N, Shigeta Y. Report of the committee on the diagnosis of diabetes mellitus. J Jpn Diabetes Soc. (1982); 25: 859-866. (in Japanese). The essence of this report appears in English; Diab Res Clin Pract. (1994); 24 (Suppl): S59–S62

Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc (1999); 42:385–404. (in Japanese); This report appears in English; Diabetes Res Clin Pract. (2002); 55:65–85

Kadowaki T, Haneda M, Tominaga M, Yamada N, Iwamoto Y, Tajima N, Noda M, Seino Y, Kashiwagi A, Kuzuya H, Ito C, Nawata H, Yamauchi T. Report of the Japan Diabetes Society’s Committee on the diagnostic criteria for diabetes mellitus and glucose metabolism disorder―a new category of fasting plasma glucose values: “high-normal”. J Jpn Diabetes Soc. 2008;51:281–3. in Japanese.

National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–57.

WHO Expert Committee on Diabetes Mellitus Second report. World Health Organ Tech Rep Ser. (1980); 646:1–80

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. (1997); 20:1183–97

Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.CrossRefPubMed

10.

Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160–7.CrossRefPubMed

11.

World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. World Health Org (2006)

12.

Shima K, Endo J, Oimomi M, Oshima I, Omori Y, Katayama Y, Kawai T, Kawamori R, Kanno T, Kiyose H, Nakashima K, Nagamine Y, Baba S, Hoshino T. Interlaboratory difference in HbA1c measurement in Japan—the interim report of the committee on an interlaboratory standardization of HbA1c determination. J Jpn Diabetes Soc. 1994;37:855–64. (in Japanese).

13.

International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. (2009); 32:1327–34

14.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. (2010); 33 Suppl 1:S62–9

15.

Kashiwagi A, Kadowaki T, Haneda M, Nawata H, Ito H, Tominaga M, Oikawa S, Noda M, Kawamura T, Sanke T, Namba M, Hashiramoto M, Sasahara T, Nishio Y, Takei I, Umemoto M, Kuwa K, Murakami M, Oguri T. Consensus and statement on international standardization of HbA1C in Japan: Committee report on diabetes mellitus laboratory testing standardization. J Jpn Diabetes Soc. 2009;52:811–8. (in Japanese).

16.

Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med. 2000;342:301–7.

17.

Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Toyoda T, Maruyama T, Makino H. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care. 2003;26:2345–52.CrossRefPubMed

18.

Imagawa A. Discovery and establishment of fulminant type 1 diabetes mellitus and new classification of type 1 diabetes mellitus based on it. J Jpn Diabetes Soc. 2004;47:796–7. (in Japanese).

19.

Kobayashi T, Sato Y, Akazawa S. The position of type 1 in the classification of diabetes mellitus. J Jpn Diabetes Soc. 1998;41:A11–3. (in Japanese).

20.

Kobayashi T. Slowly Progressive IDDM. In: Japan Diabetes Society, editors. Advances in diabetes study, vol 30. Shindan to Chiryosha; 1996. (in Japanese)

21.

Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, Furuta H, Hirota Y, Mori H, Jonsson A, Sato Y, Yamagata K, Hinokio Y, Wang HY, Tanahashi T, Nakamura N, Oka Y, Iwasaki N, Iwamoto Y, Yamada Y, Seino Y, Maegawa H, Kashiwagi A, Takeda J, Maeda E, Shin HD, Cho YM, Park KS, Lee HK, Ng MC, Ma RC, So WY, Chan JC, Lyssenko V, Tuomi T, Nilsson P, Groop L, Kamatani N, Sekine A, Nakamura Y, Yamamoto K, Yoshida T, Tokunaga K, Itakura M, Makino H, Nanjo K, Kadowaki T, Kasuga M. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet. 2008;40:1092–7.CrossRefPubMed

22.

Unoki H, Takahashi A, Kawaguchi T, Hara K, Horikoshi M, Andersen G, Ng DP, Holmkvist J, Borch-Johnsen K, Jorgensen T, Sandbaek A, Lauritzen T, Hansen T, Nurbaya S, Tsunoda T, Kubo M, Babazono T, Hirose H, Hayashi M, Iwamoto Y, Kashiwagi A, Kaku K, Kawamori R, Tai ES, Pedersen O, Kamatani N, Kadowaki T, Kikkawa R, Nakamura Y, Maeda S. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet. 2008;40:1098–102.CrossRefPubMed

23.

Kitagawa T, Owada M, Urakami T, Yamauchi K. Increased incidence of non-insulin dependent diabetes mellitus among Japanese schoolchildren correlates with an increased intake of animal protein and fat. Clin Pediatr (Phila). 1998;37:111–5.CrossRef

24.

Fajans SS. Scope and heterogeneous nature of MODY. Diabetes Care. 1990;13:49–64.CrossRefPubMed

25.

Froguel P, Vaxillaire M, Velho G. Genetic and metabolic heterogeneity of maturity-onset diabetes of the young. Diabetes Rev. 1997;5:123–30.

26.

Maassen JA, Kadowaki T. Maternally inherited diabetes and deafness: a new diabetes subtype. Diabetologia. 1996;39:375–82.CrossRefPubMed

27.

Sakagashira S, Sanke T, Hanabusa T, Shimomura H, Ohagi S, Kumagaye KY, Nakajima K, Nanjo K. Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes. 1996;45:1279–81.CrossRefPubMed

28.

Kasuga M, Kadowaki T. Insulin receptor disorders in Japan. Diabetes Res Clin Pract. 1994;24:S145–51.CrossRefPubMed

29.

Nanjo K, Oka Y, Kadowaki T, Kanatsuka A, Kuzuya T, Kobayashi M, Sanke T, Suzuki S, Seino Y. Recent aspects on diabetes mellitus associated with gene mutation in Japan. J Jpn Diabetes Soc. 1998;41:A29–31. (in Japanese).

30.

Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montminy M, Krolewski AS. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet. 1999;23:323–8.CrossRefPubMed

31.

Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, Sumnik Z, van Rhijn A, Wales JK, Clark P, Gorman S, Aisenberg J, Ellard S, Njolstad PR, Ashcroft FM, Hattersley AT. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med. 2004;350:1838–49.CrossRefPubMed

32.

Babenko AP, Polak M, Cave H, Busiah K, Czernichow P, Scharfmann R, Bryan J, Aguilar-Bryan L, Vaxillaire M, Froguel P. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med. 2006;355:456–66.CrossRefPubMed

33.

Ito C. Classification of fasting plasma glucose levels and HbA1c. Health Screen (Ningen Dock). 2008;22:874–7. (in Japanese).

34.

Tominaga M. Lifestyle habits as factors in developing diabetes mellitus—from results of Funagata research focused on prospective cohort study in Japan. J Jpn Diabetes Soc. 2008;51:473–5. (in Japanese).

35.

Kosaka K. Various parameters used for the diagnosis of diabetes and for the epidemiological investigation—their characteristics, their mutual relationship and their application. J Jpn Diabetes Soc. 1998;41:A101–5. (in Japanese).

36.

Sasaki A, Shimizu T, Hasegawa K. Study of diagnostic criteria for diabetes melliltus from a viewpoint of clinical epidemiology, In: Kosaka K, editor, Diabetology (1999); 99, Shindan to Chiryo Sha (Tokyo): 97–105. (in Japanese)

37.

Kosaka K, Hagura R, Kuzuya T, Kuzuya N. Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range. Diabetologia. 1974;10:775–82.CrossRefPubMed

38.

Seino Y, Kurahachi H, Goto Y, Taminato T, Ikeda M, Imura H. Comparative insulinogenic effects of glucose, arginine and glucagon in patients with diabetes mellitus, endocrine disorders and liver disease. Acta Diabetol Lat. 1975;12:89–99.CrossRefPubMed

39.

Seino Y, Kurahachi H, Goto Y, Taminato T, Ikeda M, Imura H. The insulinogenic index in secondary diabetes. Horm Metab Res. 1975;12:107–15.CrossRef

40.

Kosaka K, Hagura R, Kuzuya T. Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes. 1977;26:944–52.PubMed

41.

Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002.CrossRefPubMed

42.

IADPSG Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. (2010); 33:676–82

43.

Yamada K, Nonaka K. Diabetic ketoacidosis in young obese Japanese men. Diabetes Care. 1996;19:671.PubMed

44.

Ito C, Maeda R, Ishida S, Harada H, Inoue N, Sasaki H. Importance of OGTT for diagnosing diabetes mellitus based on prevalence and incidence of retinopathy. Diabetes Res Clin Pract. 2000;49:181–6.CrossRefPubMed

45.

Ito C, Maeda R, Ishida S, Sasaki H, Harada H. Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c. Diabetes Res Clin Pract. 2000;50:225–30.CrossRefPubMed

46.

Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, Bainbridge KE, Fradkin JE. Prevalence of diabetes, high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care. 2010;33:562–8.CrossRefPubMed

47.

Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362:800–11.CrossRefPubMed

48.

Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, Miedema K, Mosca A, Mauri P, Paroni R, Thienpont L, Umemoto M, Weykamp C. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med. 2002;40:78–89.CrossRefPubMed

49.

Mosca A, Goodall I, Hoshino T, Jeppsson JO, John WG, Little RR, Miedema K, Myers GL, Reinauer H, Sacks DB, Weykamp CW. Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group. Clin Chem Lab Med. 2007;45:1077–80.CrossRefPubMed

50.

Nordin G, Dybkaer R. Recommendation for term and measurement unit for “HbA1c”. Clin Chem Lab Med. 2007;45:1081–2.CrossRefPubMed

51.

Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T. Answers by Council members of JDS to a questionnaire on the diagnostic criteria and classification of diabetes mellitus. J Jpn Diabetes Soc. 1997;40:203–10. (in Japanese).

52.

McCance DR, Hanson RL, Charles MA, Jacobsson LT, Pettitt DJ, Bennett PH, Knowler WC. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ. 1994;308:1323–8.PubMed

53.

Ito C. OGTT criteria seen from the relation of fasting and 2-hPG and complications. J Jpn Diabetes Soc. 1998;41:A33–6.

54.

Kosaka K. Progress in diabetology. Diagnosis of diabetes mellitus. Critical matters on the new diagnositic criteria in the 1997 ADA report and 1998WHO report. Shindan to Chiryo. 2002;90:1851–61. (in Japanese).

55.

DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ. (1998); 317:371–5

Title: Report of the Committee on the classification and diagnostic criteria of diabetes mellitus
The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus
Authors: Yutaka Seino
Kishio Nanjo
Naoko Tajima
Takashi Kadowaki
Atsunori Kashiwagi
Eiichi Araki
Chikako Ito
Nobuya Inagaki
Yasuhiko Iwamoto
Masato Kasuga
Toshiaki Hanafusa
Masakazu Haneda
Kohjiro Ueki
Publication date: 01-11-2010
Publisher: Springer Japan
Published in: Diabetology International / Issue 1/2010
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI: https://doi.org/10.1007/s13340-010-0006-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2010

Macrophage infiltration and cytokine release in adipose tissue: angiogenesis or inflammation?

Leptin mediates the relationship between abdominal obesity and microalbuminuria in type 2 diabetic patients

Efficacy and adverse effects of low-dose nateglinide in early type 2 diabetes: comparison with acarbose in a crossover study

Different effects of islet transplantation and Detemir treatment on the reversal of streptozotocin-induced diabetes associated with β-cell regeneration

Insulin autoimmune syndrome (Hirata disease): epidemiology in Asia, including Japan

Diabetology International: our new official journal in English

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials